Unknown

Dataset Information

Predicting disease progression in high-grade glioma with neuropsychological parameters: the value of personalized longitudinal assessment.


ABSTRACT:

Purpose

Progressive disease in patients with high-grade glioma may be reflected in cognitive decline. However, the cognitive functions most sensitive to progression may differ between patients. We investigated whether decline on a personalized selection of tests predicted progressive disease according to RANO criteria in high-grade glioma patients.

Methods

Starting one day before surgery, patients underwent neuropsychological assessment every three months during standard treatment and clinical follow-up. We first made a personalized selection of three tests that showed the highest Reliable Change Index (RCI) values, i.e., most positive change, at the first post-surgical assessment for each patient. In subsequent follow up, a decline of RCI ≤ - 1 on at least two of the three

SUBMITTER: Butterbrod E 

PROVIDER: S-EPMC6764928 | biostudies-literature | 2019 Sep

REPOSITORIES: biostudies-literature